The positive correlation that we observed between IgA and BMI and the encouraging results of therapeutic approaches aimed at controlling metabolic imbalance and inflammation for halting the progression of AD [39] are noteworthy in this regard. The gene discussed is CD79A; the disease is Alzheimer disease.